Trondheim-based medtech startup VitalThings, which specializes in developing innovative healthcare technologies, recently announced that it has raised €3.16 million (NOK 35 million) in a new issue round. The startup develops medical technology for human vital signs detection and analysis. The funds will be used to obtain EU approval for Vitalthings’ latest product, a groundbreaking contactless patient monitor that could be the first of its kind.
The investment was made by a group of investors who recognize the potential of Vitalthings’ innovative products to revolutionize the healthcare industry. With this new capital, Vitalthings plans to continue its mission of creating cutting-edge solutions that improve the lives of patients and healthcare professionals alike.
The product in question is a contactless patient monitor, which could be the first of its kind. The device will help healthcare professionals provide better treatment and care to their patients by enabling them to monitor their vital signs without having to make physical contact. This is especially important in light of the COVID-19 pandemic, which has made contactless technology a necessity.
VitalThings is no stranger to success in the healthcare industry. Its digital night watchman, Somnofy, has already helped numerous users, their relatives, and healthcare professionals by providing detailed sleep analyses. With this new investment, the company is set to revolutionize patient monitoring and drive its innovative products forward.
“We are proud to be part of the healthcare technology revolution,” said a VitalThings spokesperson. “Our new investment will help us continue to create solutions with great social benefit, and we look forward to working with our partners and colleagues to bring them to life.”
VitalThings’ mission is to use technology to improve the lives of patients and healthcare professionals alike. With its innovative products and a committed team, the company is well on its way to achieving this goal.
